67 related articles for article (PubMed ID: 2501653)
1. Molecular mechanism of 7,12-dimethylbenz[a]anthracene-induced immunosuppression: evidence for action via the interleukin-2 pathway.
Pallardy MJ; House RV; Dean JH
Mol Pharmacol; 1989 Jul; 36(1):128-33. PubMed ID: 2501653
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of dimethylbenzanthracene-induced immunotoxicity.
Dean JH; Ward EC; Murray MJ; Lauer LD; House RV
Clin Physiol Biochem; 1985; 3(2-3):98-110. PubMed ID: 3924465
[TBL] [Abstract][Full Text] [Related]
3. Suppression of T-helper cell function in mice following exposure to the carcinogen 7,12-dimethylbenz[a]anthracene and its restoration by interleukin-2.
House RV; Lauer LD; Murray MJ; Dean JH
Int J Immunopharmacol; 1987; 9(1):89-97. PubMed ID: 2953689
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
Chouaib S; Welte K; Mertelsmann R; Dupont B
J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
[TBL] [Abstract][Full Text] [Related]
5. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
Han SB; Park SH; Jeon YJ; Kim YK; Kim HM; Yang KH
J Pharmacol Exp Ther; 2001 Nov; 299(2):415-25. PubMed ID: 11602650
[TBL] [Abstract][Full Text] [Related]
6. Restricted expression of mitogen-induced high affinity IL-2 receptors in aging mice.
Proust JJ; Kittur DS; Buchholz MA; Nordin AA
J Immunol; 1988 Dec; 141(12):4209-16. PubMed ID: 3264308
[TBL] [Abstract][Full Text] [Related]
7. Suppression of splenic lymphocyte function by 7,12-dimethylbenz[a]anthracene (DMBA) in vitro.
Thurmond LM; House RV; Lauer LD; Dean JH
Toxicol Appl Pharmacol; 1988 May; 93(3):369-77. PubMed ID: 2835829
[TBL] [Abstract][Full Text] [Related]
8. Persistent suppression of humoral and cell-mediated immunity in mice following exposure to the polycyclic aromatic hydrocarbon 7,12-dimethylbenz[a]anthracene.
Ward EC; Murray MJ; Lauer LD; House RV; Dean JH
Int J Immunopharmacol; 1986; 8(1):13-22. PubMed ID: 3082776
[TBL] [Abstract][Full Text] [Related]
9. Induction of PreB cell apoptosis by 7,12-dimethylbenz[a]anthracene in long-term primary murine bone marrow cultures.
Yamaguchi K; Matulka RA; Shneider AM; Toselli P; Trombino AF; Yang S; Hafer LJ; Mann KK; Tao XJ; Tilly JL; Near RI; Sherr DH
Toxicol Appl Pharmacol; 1997 Dec; 147(2):190-203. PubMed ID: 9439715
[TBL] [Abstract][Full Text] [Related]
10. 7-12 Dimethylbenz[a]anthracene-induced bone marrow hypocellularity is dependent on signaling through both the TNFR and PKR.
Page TJ; MacWilliams PS; Suresh M; Jefcoate CR; Czuprynski CJ
Toxicol Appl Pharmacol; 2004 Jul; 198(1):21-8. PubMed ID: 15207645
[TBL] [Abstract][Full Text] [Related]
11. Alterations in murine fetal thymus and liver hematopoietic cell populations following developmental exposure to 7,12-dimethylbenz[a]anthracene.
Holladay SD; Smith BJ
Environ Res; 1995 Feb; 68(2):106-13. PubMed ID: 7601071
[TBL] [Abstract][Full Text] [Related]
12. Functional and biochemical disposition of 7,12-dimethylbenz[a]anthracene in murine lymphoid cells.
Thurmond LM; Tucker AN; Rickert DE; Lauer LD; Dean JH
Chem Biol Interact; 1989; 72(1-2):93-104. PubMed ID: 2510951
[TBL] [Abstract][Full Text] [Related]
13. Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivo.
Wang JX; Tang W; Yang ZS; Wan J; Shi LP; Zhang Y; Zhou R; Ni J; Hou LF; Zhou Y; He PL; Yang YF; Li Y; Zuo JP
Eur J Pharmacol; 2007 Jun; 564(1-3):211-8. PubMed ID: 17349993
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of mitogen-induced lymphocyte proliferation by ouabain: interference with interleukin 2 production and interleukin 2 action.
Stoeck M; Northoff H; Resch K
J Immunol; 1983 Sep; 131(3):1433-7. PubMed ID: 6604100
[TBL] [Abstract][Full Text] [Related]
15. Effects of methyl substitutions on benz[a]anthracene derivatives-induced immunosuppression.
Saas P; Bohuon C; Pallardy M
J Toxicol Environ Health; 1996 Nov; 49(4):371-87. PubMed ID: 8931739
[TBL] [Abstract][Full Text] [Related]
16. Unresponsiveness to Con A in spleen cell cultures of M. lepraemurium-infected mice is dependent on a defective expression of high-affinity IL-2 receptors rather than on a lack of IL-2 production.
Turcotte R; Lemieux S
Clin Exp Immunol; 1989 Apr; 76(1):126-31. PubMed ID: 2661060
[TBL] [Abstract][Full Text] [Related]
17. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
Tadmori W; Reed JC; Nowell PC; Kamoun M
J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
[TBL] [Abstract][Full Text] [Related]
18. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
19. Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz[a]anthracene metabolites and inhibition of immunosuppression by alpha-naphthoflavone.
Ladics GS; Kawabata TT; White KL
Toxicol Appl Pharmacol; 1991 Aug; 110(1):31-44. PubMed ID: 1908145
[TBL] [Abstract][Full Text] [Related]
20. Murine leukemic cells inhibit IL 2 production by susceptible syngeneic splenocytes.
Jenski LJ; Ledford T
J Immunol; 1985 Nov; 135(5):3178-83. PubMed ID: 2931479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
